Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	136.74	265.38	112.09
Graham Fair Price	-20.73	89301.15	112659.48
PEG	-8.38	-2.11	2.31
Price/Book	1.56	5.80	5.71
Price/Cash Flow	211.87	328.06	105.19
Prices/Earnings	67.61	80.95	48.30
Price/Sales	17.25	61.33	52.31
Price/FCF	211.87	328.06	105.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-12.41	0.43	0.49
Operating Margin	-28.31	0.23	0.33
ROA	-40.08	0.01	0.02
ROE	0.03	0.02	-39.40
ROIC	0.02	0.01	-41.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.10	-0.13	19.85
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.10	-0.37	272.53
EPS QOQ	0.21	-0.38	82.94
FCF QOQ	3.04	-0.67	-78.04
Revenue QOQ	0.04	-0.12	208.44
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	438.41	446.48	1.84
Days Sales Outstanding (DSO)	69.11	72.27	4.58
Inventory Turnover	0.21	0.20	-1.81
Debt/Capitalization	0.16	0.14	-13.59
Quick Ratio	0.69	0.60	-13.71
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	138119.15	140644.58	1.83
Cash	28890.83	28340.14	-1.91
Capex	-4201.19	-1585.00	62.27
Free Cash Flow	7500.54	2487.32	-66.84
Revenue	15082.88	13304.06	-11.79
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.33	1.21	-9.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.99	2.94	-1.96
Naive Interpretation	Member

06 - Financial Health · Weak

Rating